Australia's Proteomics International jumps on endometriosis panel results

Proteomics International Laboratories

30/12/2024 01:09

** Shares of Proteomics International Laboratories  PIQ.AX 
surge as much as 24% to A$0.750, their biggest one-day pct gain
since Oct. 8
    ** Medical technology firm reports that its PromarkerEndo
plasma protein biomarker panel accurately identifies all stages
of endometriosis
    ** Endometriosis is a condition causing uterine-like tissue
growth outside the uterus, affecting roughly 10% of reproductive
age women and girls according to the WHO
    ** The condition takes an average of seven years to diagnose
    ** PIQ sets sights on Q2 CY25 for Australian launch of its
product
    ** Stock hits its highest level since Oct. 29
    ** Including session's moves, stock trims YTD losses to 19%
as of 0050 GMT

 (Reporting by Kumar Tanishk in Bengaluru)
 ((Tanishk.Kumar@thomsonreuters.com;))